Skip to content

SYRS SYROS PHARMACEUTICALS INC COM

Follow

COM NEW (common)

7 managers (7 13F filers) reported a position in SYRS shares at 2025-03-31, 483,185 shares in all. 1 filer opened a position and 39 filers sold out during the quarter.

Managers
7
13F filers
7
New
1
Added
3
Reduced
1
Sold out
39
Shares held by filers
483,185

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
ACADIAN ASSET MANAGEMENT LLCin group ACADIAN ASSET MANAGEMENT LLC329,793$9K<0.01%+80,36713F-HRTimelineGroup
Baader Bank Aktiengesellschaft83,864$1.91K<0.01%+61,77213F-HRTimeline
1492 Capital Management LLC39,244$1.18K<0.01%013F-HRTimeline
XTX Topco Ltdin group XTX Topco Ltd10,053$290<0.01%-71,40713F-HRTimelineGroup
FNY Investment Advisers, LLC16,100$00%+11,00013F-HRTimelineValue filed as zero, left out of ratios.
SIMPLEX TRADING, LLC4,123$00%new13F-HRTimelineValue filed as zero, left out of ratios.
Steward Partners Investment Advisory, L…8$00%013F-HRTimelineValue filed as zero, left out of ratios.